Immune cell profiling and antibody responses in patients with COVID-19

被引:16
|
作者
Rezaei, Mitra [1 ]
Mahmoudi, Shima [2 ]
Mortaz, Esmaeil [3 ]
Marjani, Majid [3 ]
机构
[1] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Virol Res Ctr, Tehran, Iran
[2] Univ Tehran Med Sci, Childrens Med Ctr Hosp, Pediat Ctr Excellence, Pediat Infect Dis Res Ctr, Dr Gharib St,Keshavarz Blvd, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Clin TB & Epidemiol Res Ctr, Tehran, Iran
关键词
SARS-CoV-2; COVID-19; Antibody response; Lymphocyte subsets;
D O I
10.1186/s12879-021-06278-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundAlthough there are a growing number of studies on evaluating lymphocyte subset counts as prognostic factors for COVID-19 disease severity, the lymphocyte subsets' analyses of both IgM and IgG responders and non-responders during the periods after onset of symptoms, have not been conducted yet. So, this study aimed to evaluate immune cell profiling of COVID-19 patients with and without antibody responses.MethodsIn this cross-sectional study, the levels of peripheral lymphocyte subsets were measured using flow cytometry in 53 patients with positive SARS-CoV-2 RT-PCR, for whom antibody testing of COVID-19 was performed.ResultsThe white blood cell, neutrophil, and lymphocyte counts consistently decreased in the IgM and IgG non-responder group, while the differences in the median value between the two study groups were found to be statistically significant only in terms of neutrophil counts (P=0.024 for IgM response and p-value= 0.046 for IgG response, respectively). Moreover, the level of neutrophil-to-lymphocyte ratio was observed to be significantly lower in the IgM or IgG non-responder group compared to the IgM or IgG responder group (3.63.1 vs. 6.3 +/- 4.2; p-value= 0.021). The patients with IgM antibody response had a significantly lower CD20(+) lymphocytes (11% versus 15% in the groups without IgM antibody response, p-value= 0.031), The percentages of NK cells and CD4(+) T cells significantly increased in the patients with IgG antibody response compared to those without IgG antibody response (13% versus 10%, p-value= 0.028, and 41.5% versus 34%; p-value= 0.03, respectively). Moreover, the patients who produced IgM or IgG antibody had significantly higher percentages of total T lymphocytes (64% versus 54%; p-value= 0.017), CD4(+) T cells (41% versus 34%; p-value=0.038), and NK cells (13% versus 9%, p-value=0.023) compared to the group with no serological response. No significant difference was observed in the percentage of other lymphocyte subsets, including CD8(+) T cells, T-reg cells, and CD19(+) B cells.Conclusion Our results suggest that the total T cells, CD4(+) T cells, and NK cells percentages are linked to serological response. Moreover, our findings suggested that neutrophil absolute counts and neutrophil-to-lymphocyte ratio may be valuable predictors of IgM or IgG antibody response.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Cell specific peripheral immune responses predict survival in critical COVID-19 patients
    Amrute, Junedh M.
    Perry, Alexandra M.
    Anand, Gautam
    Cruchaga, Carlos
    Hock, Karl G.
    Farnsworth, Christopher W.
    Randolph, Gwendalyn J.
    Lavine, Kory J.
    Steed, Ashley L.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [32] Complexity of immune responses in COVID-19
    Mather, Michael William
    Jardine, Laura
    Talks, Ben
    Gardner, Louis
    Haniffa, Muzlifah
    SEMINARS IN IMMUNOLOGY, 2021, 55
  • [33] Gut Microbiome affects Immune Responses in COVID-19 Patients
    Franke, Katharina
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2023, 61 (07):
  • [34] Integrated immune dynamics define correlates of COVID-19 severity and antibody responses
    Koutsakos, Marios
    Rowntree, Louise C.
    Hensen, Luca
    Chua, Brendon Y.
    van de Sandt, Carolien E.
    Habel, Jennifer R.
    Zhang, Wuji
    Jia, Xiaoxiao
    Kedzierski, Lukasz
    Ashhurst, Thomas M.
    Putri, Givanna H.
    Marsh-Wakefield, Felix
    Read, Mark N.
    Edwards, Davis N.
    Clemens, E. Bridie
    Wong, Chinn Yi
    Mordant, Francesca L.
    Juno, Jennifer A.
    Amanat, Fatima
    Audsley, Jennifer
    Holmes, Natasha E.
    Gordon, Claire L.
    Smibert, Olivia C.
    Trubiano, Jason A.
    Hughes, Carly M.
    Catton, Mike
    Denholm, Justin T.
    Tong, Steven Y. C.
    Doolan, Denise L.
    Kotsimbos, Tom C.
    Jackson, David C.
    Krammer, Florian
    Godfrey, Dale, I
    Chung, Amy W.
    King, Nicholas J. C.
    Lewin, Sharon R.
    Wheatley, Adam K.
    Kent, Stephen J.
    Subbarao, Kanta
    McMahon, James
    Thevarajan, Irani
    Thi H O Nguyen
    Cheng, Allen C.
    Kedzierska, Katherine
    CELL REPORTS MEDICINE, 2021, 2 (03)
  • [35] The concentrated antibody from convalescent plasma balanced the dysfunctional immune responses in patients with critical COVID-19
    Liao, Mingfeng
    Liao, Xuejiao
    Yuan, Jing
    Zhou, Bing
    Liu, Yang
    Jiang, Xiao
    Zhang, Zhan
    Guo, Caiping
    Zhang, Yunjia
    Zhang, Shuye
    Liu, Lei
    Zhang, Zheng
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (11):
  • [36] COVID-19 in patients with B cell immune deficiency
    Vergidis, Paschalis
    Levy, Emily R.
    Ristagno, Elizabeth H.
    Iyer, Vivek N.
    O'Horo, John C.
    Joshi, Avni Y.
    JOURNAL OF IMMUNOLOGICAL METHODS, 2022, 510
  • [37] Immune Responses in Discharged COVID-19 Patients With and Without Long COVID Symptoms
    Wang, Yeming
    Guo, Li
    Cui, Dan
    Zhang, Hui
    Zhang, Qiao
    Ren, Lili
    Wang, Geng
    Zhang, Xueyang
    Huang, Tingxuan
    Chen, Lan
    Huang, Lixue
    Wang, Xinming
    Zhong, Jinchuan
    Wang, Ying
    Li, Hui
    Wang, Jianwei
    Cao, Bin
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (04):
  • [38] Author Correction: Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
    Wen Wen
    Wenru Su
    Hao Tang
    Wenqing Le
    Xiaopeng Zhang
    Yingfeng Zheng
    Xiuxing Liu
    Lihui Xie
    Jianmin Li
    Jinguo Ye
    Liwei Dong
    Xiuliang Cui
    Yushan Miao
    Depeng Wang
    Jiantao Dong
    Chuanle Xiao
    Wei Chen
    Hongyang Wang
    Cell Discovery, 6
  • [39] Antibody responses to SARS-CoV-2 in patients with COVID-19
    Long, Quan-Xin
    Liu, Bai-Zhong
    Deng, Hai-Jun
    Wu, Gui-Cheng
    Deng, Kun
    Chen, Yao-Kai
    Liao, Pu
    Qiu, Jing-Fu
    Lin, Yong
    Cai, Xue-Fei
    Wang, De-Qiang
    Hu, Yuan
    Ren, Ji-Hua
    Tang, Ni
    Xu, Yin-Yin
    Yu, Li-Hua
    Mo, Zhan
    Gong, Fang
    Zhang, Xiao-Li
    Tian, Wen-Guang
    Hu, Li
    Zhang, Xian-Xiang
    Xiang, Jiang-Lin
    Du, Hong-Xin
    Liu, Hua-Wen
    Lang, Chun-Hui
    Luo, Xiao-He
    Wu, Shao-Bo
    Cui, Xiao-Ping
    Zhou, Zheng
    Zhu, Man-Man
    Wang, Jing
    Xue, Cheng-Jun
    Li, Xiao-Feng
    Wang, Li
    Li, Zhi-Jie
    Wang, Kun
    Niu, Chang-Chun
    Yang, Qing-Jun
    Tang, Xiao-Jun
    Zhang, Yong
    Liu, Xia-Mao
    Li, Jin-Jing
    Zhang, De-Chun
    Zhang, Fan
    Liu, Ping
    Yuan, Jun
    Li, Qin
    Hu, Jie-Li
    Chen, Juan
    NATURE MEDICINE, 2020, 26 (06) : 845 - +
  • [40] Modeling of antibody responses to COVID-19 vaccination in patients with rheumatoid arthritis
    Kim, Yun Kyu
    Choi, Yunhee
    Jung, Ji In
    Kim, Ju Yeon
    Kim, Mi Hyeon
    Curtis, Jeffrey
    Lee, Eun Bong
    SCIENTIFIC REPORTS, 2024, 14 (01)